Yoshiko Iwamoto Selected Research

4-aminobenzhydrazide

10/2019	Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
2/2019	Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiko Iwamoto Research Topics

Disease

23	Inflammation (Inflammations) 01/2021 - 11/2010
17	Neoplasms (Cancer) 06/2022 - 02/2004
12	Atherosclerosis 01/2022 - 01/2012
12	Myocardial Infarction 12/2017 - 07/2009
9	Infarction (Infarctions) 12/2016 - 11/2010
7	Atherosclerotic Plaque (Atheroma) 10/2020 - 05/2011
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2019 - 01/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2016
4	Multiple Sclerosis 10/2019 - 05/2012
4	Hypertension (High Blood Pressure) 01/2019 - 01/2014
4	Heart Failure 09/2016 - 04/2014
3	Infections 01/2022 - 06/2014
3	Demyelinating Diseases (Demyelinating Disease) 10/2019 - 01/2012
3	Neuroinflammatory Diseases 10/2019 - 01/2012
3	Rupture 11/2017 - 07/2012
3	Ischemia 11/2017 - 11/2010
2	Fibrosis (Cirrhosis) 12/2020 - 12/2015
2	Atrial Fibrillation 12/2020 - 04/2012
2	Endocarditis 11/2020 - 08/2011
2	Myocarditis (Carditis) 01/2019 - 06/2015
2	Non-alcoholic Fatty Liver Disease 01/2017 - 12/2015
2	Chronic Disease (Chronic Diseases) 01/2016 - 05/2015
2	Stroke (Strokes) 07/2014 - 07/2012
2	Wounds and Injuries (Trauma) 04/2014 - 11/2010
2	Disease Progression 03/2013 - 04/2009
1	Human Influenza (Influenza) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Anaplastic Thyroid Carcinoma 01/2021
1	Communicable Diseases (Infectious Diseases) 11/2020
1	Diabetes Mellitus 01/2020
1	Lung Injury 11/2019
1	Sleep Deprivation 01/2019
1	Hyperplasia 01/2019
1	Obesity 01/2019
1	Bites and Stings (Sting) 12/2017

Drug/Important Bio-Agent (IBA)

13	Peroxidase (Myeloperoxidase)IBA 01/2022 - 07/2011
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
7	EnzymesIBA 01/2022 - 02/2004
6	Pharmaceutical PreparationsIBA 01/2021 - 12/2012
6	Apolipoproteins E (ApoE)IBA 11/2015 - 11/2010
5	CytokinesIBA 03/2015 - 12/2012
4	Interleukin-3 (Interleukin 3)IBA 01/2021 - 01/2012
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2017 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 02/2019 - 01/2012
3	ChemokinesIBA 01/2019 - 01/2012
3	LipidsIBA 01/2016 - 05/2011
3	CollagenIBA 09/2015 - 06/2013
3	Chemokine ReceptorsIBA 06/2015 - 02/2012
3	Small Interfering RNA (siRNA)IBA 06/2015 - 05/2013
3	Messenger RNA (mRNA)IBA 06/2015 - 10/2011
2	Contrast MediaIBA 01/2022 - 01/2012
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022 - 05/2015
2	Leptin ReceptorsIBA 01/2020 - 11/2019
2	4-aminobenzhydrazideIBA 10/2019 - 02/2019
2	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2015
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 01/2015
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 01/2015
2	Therapeutic UsesIBA 12/2016 - 06/2015
2	GadoliniumIBA 05/2015 - 07/2011
2	Peptide Hydrolases (Proteases)FDA Link 04/2014 - 01/2012
2	Factor XIII (Coagulation Factor XIII)IBA 05/2013 - 11/2012
2	ApolipoproteinsIBA 05/2013 - 11/2010
2	Gadolinium DTPA (Magnevist)FDA Link 01/2012 - 01/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2012 - 01/2012
1	HydrogelsIBA 06/2022
1	CarcinogensIBA 01/2022
1	Versicans (Versican)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2021
1	2- (1,1- dicyanopropenyl- 2- )- 6- dimethylaminonaphthaleneyIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	ibrutinibIBA 12/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2020
1	CSK Tyrosine-Protein KinaseIBA 12/2020
1	Virulence Factors (Pathogenicity Factors)IBA 11/2020
1	Growth Factor ReceptorsIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2019
1	LeptinIBA 11/2019
1	Immunomodulating AgentsIBA 10/2019
1	Glatiramer Acetate (Copaxone)FDA Link 10/2019
1	NeuropeptidesIBA 01/2019
1	SugarsIBA 01/2019
1	OrexinsIBA 01/2019
1	matrigelIBA 01/2019
1	IntegrinsIBA 01/2019
1	IncretinsIBA 01/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2019
1	Orexin ReceptorsIBA 01/2019
1	TabletsIBA 01/2018
1	Neutralizing AntibodiesIBA 12/2017

Therapy/Procedure

14	Therapeutics 01/2021 - 04/2009
6	Ligation 09/2016 - 11/2010
3	Immunotherapy 01/2021 - 02/2016
1	Intravenous Administration 10/2020